# US 2026/0077170 A1 · Microneedle drug delivery apparatus and preparation method thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0077170 A1
- Document ID: US20260077170A1
- Status: Published application
- Kind: A1
- Application number: 19/403,032
- Filed: 2025-11-27
- Published: 2026-03-19
- Earliest claimed: 2023-05-31
- Assignees: Tsinghua University
- Applicants: Tsinghua University
- Inventors: Mingjun ZHANG; Xize GAO; Jiacong LI; Jing LI; Jing XU; Mingxiao XIE; Hongru LIU; Longxi REN
- Web page: https://patentgrep.com/patent/US20260077170A1

## CPC

- A61K 9/0021: {Intradermal administration, e.g. through microneedle arrays or needleless injectors}
- A61M 37/0015: {by using microneedles}
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- A61M 2037/0023: {Drug applicators using microneedles}
- A61M 2037/0046: {Solid microneedles}
- A61M 2037/0053: {Methods for producing microneedles}
- A61M 2037/0061: {Methods for using microneedles}
- A61M 2205/02: characterised by a particular materials
- A61M 2210/106: Small intestine
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

The present application relates to the technical field of drug delivery, and particularly, to a microneedle drug delivery apparatus and a preparation method thereof. The apparatus includes: a substrate; an array of microneedles loaded on the substrate; and a liquid-absorbing swellable material wrapped by the substrate to form a closed sandwich structure. This microneedle drug delivery apparatus allows microneedles to penetrate an intestinal wall using a mild water-absorbing swellable mechanism and natural peristaltic behavior of a gastrointestinal tract, to complete drug delivery. It penetrates a physiological barrier of oral delivery and absorption of biologic drugs by physical means, improving oral bioavailability of biologic drugs. Also, all materials used are biodegradable soft materials, with high safety.

## Claims

### Claim 1

A microneedle drug delivery apparatus, comprising:
a substrate;
an array of microneedles loaded on the substrate, the microneedles carrying a drug at tips of the microneedles; and
a liquid-absorbing swellable material wrapped by the substrate to form a closed sandwich structure.

### Claim 2 (depends on 1)

The microneedle drug delivery apparatus according to claim 1, wherein the drug comprises at least one selected from a biologic macromolecular drug and a chemical small-molecule drug,
optionally, the biologic macromolecular drug comprises at least one selected from a peptide drug, a protein drug, a glycan drug, and a nucleic acid drug.

### Claim 3 (depends on 1)

The microneedle drug delivery apparatus according to claim 1, wherein:
the microneedles contained in the array of microneedles have each a monolayer conical shape or a barbed structure; and
the number of the microneedles ranges from 1 to 1,000.

### Claim 4 (depends on 3)

The microneedle drug delivery apparatus according to claim 3, wherein the barbed structure comprises at least one selected from a pine tree-like shape, a tower-like shape, or a thorn-like shape.

### Claim 5 (depends on 1)

The microneedle drug delivery apparatus according to claim 1, wherein the microneedles contained in the array of microneedles have each a length ranging from 30 μm to 5,000 μm, a bottom dimension ranging from 10 μm to 5,000 μm, and a tip dimension ranging from 1 μm to 300 μm, the bottom dimension being greater than or equal to the tip dimension.

### Claim 6 (depends on 1)

The microneedle drug delivery apparatus according to claim 1, wherein:
the substrate is a flexible and stretchable substrate; and
the substrate is made of a material comprising at least one selected from sodium alginate, chitosan, cellulose, and polyvinyl alcohol.

### Claim 7 (depends on 1)

The microneedle drug delivery apparatus according to claim 1, wherein a surface of the substrate has a structure of micropores, wherein the micropores have each a diameter ranging from 10 μm to 1,000 μm, and a density of the micropores ranges from 0.01/mm2 to 1,000/mm2.

### Claim 8 (depends on 1)

The microneedle drug delivery apparatus according to claim 1, wherein the liquid-absorbing swellable material comprises at least one selected from a water-absorbing gel, a water-absorbing rubber, and a water-absorbing resin.

### Claim 9 (depends on 1)

The microneedle drug delivery apparatus according to claim 1, wherein the liquid-absorbing swellable material is selected from a water-absorbing polymeric resin, wherein the water-absorbing polymeric resin has a particle size ranging from 0.01 mm to 20 mm.

### Claim 10 (depends on 1)

The microneedle drug delivery apparatus according to claim 1, further comprising a controllable exposure device, wherein the substrate, the array of microneedles, and the liquid-absorbing swellable material are encapsulated in the controllable exposure device, and wherein the controllable exposure device comprises an enteric coating.

### Claim 11 (depends on 1)

The microneedle drug delivery apparatus according to claim 1, wherein a dimension of the microneedle drug delivery apparatus at swelling equilibrium does not exceed an inner diameter of an intestinal lumen of a subject.

### Claim 12 (depends on 1)

A method for preparing the microneedle drug delivery apparatus according to claim 1, the method comprising:
step 1 of preparing an array of microneedles;
step 2 of preparing a substrate, and loading the array of microneedles obtained in step 1 onto a surface of the substrate to obtain a substrate-microneedle array structure; and
step 3 of preparing a liquid-absorbing swellable material, and placing the liquid-absorbing swellable material inside the substrate of the substrate-microneedle array structure obtained in step 2 to form a closed sandwich structure.

### Claim 13 (depends on 12)

The method according to claim 12, wherein said preparing the array of microneedles in step 1 comprises: mixing the drug with a polymer solution 1, filling the mixture into a needle tip position of a mold, and performing photo-crosslinking to obtain the array of microneedles,
wherein a polymer of the polymer solution 1 comprises at least one selected from methacrylated gelatin, methacrylated dextran, methacrylated sodium alginate, methacrylated hyaluronic acid, polyethylene glycol diacrylate, or polyethylene glycol.

### Claim 14 (depends on 12)

The method according to claim 12, wherein said preparing the substrate in step 2comprises: placing a polymer solution 2 into a mold, performing photo-crosslinking on the polymer solution 2 and the array of microneedles obtained in step 1, and demolding, to obtain the substrate-microneedle array structure,
wherein a polymer in the polymer solution 2 comprises at least one selected from a polymer with a photo-crosslinking group, a polymer monomer molecule with a photo-crosslinking group, and a composite of a polymer without a photo-crosslinking group and a polymer monomer molecule with a photo-crosslinking group, wherein:
the polymer with a photo-crosslinking group comprises at least one selected from methacrylated gelatin, methacrylated chitosan, polyether F127 acrylate, or polyethylene glycol acrylate;
the polymer without a photo-crosslinking group comprises at least one selected from polyvinyl alcohol, sodium alginate, chitosan, or cellulose; and
the polymer monomer molecule with a photo-crosslinking group comprises at least one selected from acrylamide, acrylic acid, N,N-methylene acrylamide, or methyl acrylate.

### Claim 15 (depends on 12)

The method according to claim 12, wherein step 3 further comprises:
preparing a natural water-absorbing polymeric resin, placing the natural water-absorbing polymeric resin inside the substrate of the substrate-microneedle array structure prepared in step 2 to form the closed sandwich structure, to obtain the microneedle drug delivery apparatus,
wherein in step 3, the natural water-absorbing polymeric resin is placed in a cavity formed by the substrate, and the natural water-absorbing polymeric resin is connected to the substrate using biologic glue or by means of hot pressing,
wherein a raw material for preparing the liquid-absorbing swellable material in step 3 comprises a water-absorbing polymer and a crosslinking agent, wherein:
the water-absorbing polymer comprises at least one selected from sodium carboxymethyl cellulose, carboxymethyl chitosan, sodium carboxymethyl alginate, or hyaluronic acid; and
the crosslinking agent comprises at least one selected from citric acid, 1-ethyl-(3-dimethylaminopropyl)carbodiimide, glutaraldehyde, or genipin.

### Claim 16 (depends on 13)

The method according to claim 13, wherein said photo-crosslinking in step 1 comprises:
mixing the drug, the polymer solution 1, and a photoinitiator 1 to obtain a photo-crosslinking solution;
dropwise adding the photo-crosslinking solution into the needle tip position of the mold;
filling the photo-crosslinking solution at the needle tip position sufficiently, by means of ultrasound, centrifugation, or evacuation; and
performing crosslinking, wherein the photoinitiator 1 comprises at least one selected from benzoin and derivatives thereof, benzoyl compounds, alkyl phenones, acylphosphine oxides, or benzophenones.

### Claim 17 (depends on 14)

The method according to claim 14, wherein said photo-crosslinking in step 2 comprises:
mixing the polymer solution 2 with a photoinitiator 2;
placing the mixture in a mold; and
performing ultraviolet crosslinking in an ice-water bath, wherein the photoinitiator 2 comprises at least one selected from benzoin and derivatives thereof, benzoyl compounds, alkyl phenones, acylphosphine oxides, or benzophenones.

### Claim 18 (depends on 14)

The method according to claim 14, wherein step 2 further comprises, subsequent to said photo-crosslinking:
performing a freeze-thaw cycling treatment.

### Claim 19 (depends on 1)

A medicament, comprising:
the microneedle drug delivery apparatus according to claim 1; and
an active pharmaceutical ingredient.

### Claim 20 (depends on 1)

A method for preparing a medicament, the method comprising:
placing an active pharmaceutical ingredient into microneedles of the microneedle drug delivery apparatus according to claim 1.
